Miscarriage and clinical correlates of leukocyte count in patients with ovarian hyperstimulation syndrome

References

• Abramov Y, Schenker J G, Lewin A, Friedler S, Nisman B, Barak V. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Human Reproduction 1996; 11: 1381–1386
   PubMed Web of Science ®Google Scholar
• Balasch J, Fabregues F, Arroyo V. Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome. Human Reproduction 1998; 13: 2718–2730
   PubMed Web of Science ®Google Scholar
• Berg P A, Navot D. Ovarian hyperstimulation syndrome: a review of pathophysiology. Journal of Assisted Reproduction and Genetics 1992; 9: 429–438
   PubMedGoogle Scholar
• Chen C D, Wu M Y, Chao K H, Chen S U, Ho H N, Yang Y S. Serum estradiol level and oocyte number in predicting severe ovarian hyperstimulation syndrome. Journal of the Formosan Medical Association 1997; 96: 829–834
   PubMedGoogle Scholar
• Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome. Human Reproduction Update 2003; 9: 77–96
   PubMed Web of Science ®Google Scholar
• Dulitzky M, Cohen S B, Inbal A, Seidman D S, Soriano D, Lidor A, et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertility and Sterility 2002; 77: 463–467
   PubMed Web of Science ®Google Scholar
• Fabreggues F, Balasch J, Manau D, Jimenez W, Arroyo V, Creus M, et al. Hematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Human Reproduction 1998; 13: 2406–2410
   PubMedGoogle Scholar
• Friedlander M A, Loret de Mola J R, Goldfarb J M. Elevated levels of interleukin-6 in ascetic and serum from women with ovarian hyperstimulation syndrome. Fertility and Sterility 1993; 60: 826–833
   PubMed Web of Science ®Google Scholar
• Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Capsi E. Ovarian hyperstimulation syndrome: an update review. Obstetrics and Gynecology Survey 1989; 44: 430–440
   PubMedGoogle Scholar
• Goldsman M P, Pedram A, Dominguez C E, Ciuffardi I, Levin E, Asch R H. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertility and Sterility 1995; 63: 268–272
   PubMed Web of Science ®Google Scholar
• Hill J A. Cytokines considered critical in pregnancy. American Journal of Obstetrics and Gynecology 1992; 28: 123–126
   Google Scholar
• Hollen C W, Henthorn J, Koziol J A, Burstein S A. Elevated serum interleukin-6 in patients with reactive thrombocytosis. British Journal of Haematology 1991; 79: 286–290
   PubMed Web of Science ®Google Scholar
• Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. Characteristics of blood haemostatic markers in patients with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertility and Sterility 1995; 64: 1207–1209
   PubMedGoogle Scholar
• Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertility and Sterility 1996; 66: 417–424
   PubMed Web of Science ®Google Scholar
• Lim K JH, Odukoya O A, Li T C, Cooke I D. Cytokines and immuno-endocrine factors in recurrent miscarriage. Human Reproduction Update 1996; 2: 469–481
   PubMedGoogle Scholar
• Loret de Mola J R, Baumgardner G P, Goldfarb J M, Friedlander M A. Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumor necrosis factor-alpha cannot predict its occurrence. Human Reproduction 1996; 11: 1377–1380
   PubMedGoogle Scholar
• Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortion. Human Reproduction 2000; 15: 2011–2017
   PubMed Web of Science ®Google Scholar
• Navot D, Berg P A, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertility and Sterility 1992; 58: 249–261
   PubMed Web of Science ®Google Scholar
• Navot D, Berg P A, Laufer N. The ovarian hyperstimulation syndrome. Reproductive endocrinology, surgery, and technology, E Y Adashi, J A Rock, Z Rosenwaks. Lippincott-Raven, Philadelphia 1996; 2: 2215–2332
   Google Scholar
• Orvieto R, Voliovitch I, Fishman P, Ben-Rafael Z. Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. Human Reproduction 1995; 10: 24–27
   PubMed Web of Science ®Google Scholar
• Qublan H S, Amarin Z, Tahat Y A, Smadi A Z, Kilani M. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact. Human Reproduction 2006; 21: 640–644
   PubMed Web of Science ®Google Scholar
• Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R. Cytokines production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Human Reproduction 2000; 15: 713–718
   PubMed Web of Science ®Google Scholar
• Raziel A, Friedler S, Schachter M, Strassburger D, Mordechai E, Ron-El R. Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome. Human Reproduction 2002; 17: 107–110
   PubMedGoogle Scholar
• Robertson S A, Seamark R F, Guilbert L J, Wegmann T G. The role of cytokines in gestation. Critical Reviews in Immunology 1994; 14: 239–292
   PubMed Web of Science ®Google Scholar
• Simón C, Martín J C, Pellicer A. Paracrine regulators of implantation. Bailliere's best practice & research. Clinical Obstetrics & Gynaecology 2000; 14: 815–826
   PubMed Web of Science ®Google Scholar
• Wegmann T G, Lin H, Guilbert L, Mosmann T R. Bi-directional cytokines interaction in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunology Today 1993; 14: 353–356
   PubMedGoogle Scholar
• Whelan J G, 3rd, Vlahos N F. The ovarian hyperstimulation syndrome. Fertility and Sterility 2000; 73: 883–896
   PubMed Web of Science ®Google Scholar